icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
Barcelona, Spain
13-17 April 2016
Back grey_arrow_rt.gif
 
 
 
Reductions in Lifetime Risks of Liver-Related Morbidity and Mortality Associated with Novel Direct-Acting Antiviral Regimens Recommended for Treating Genotype 4 Non-Cirrhotic Hepatitis C Patients in the United States
 
 
  Reported by Jules Levin
EASL 2016 April 14-17 Barcelona
 
Sammy Saab1, Helene Parise2, Suchin Virabhak2, Alice Wang3, Steven E. Marx3, Scott J. Johnson2
1Pfleger Liver Institute, University of California at Los Angeles, Los Angeles, CA, USA; 2Medicus Economics LLC, Milton, MA, USA; 3AbbVie Inc., North Chicago, IL, USA

EASL1

EASL2

EASL3

EASL4

EASL5

EASL6